NYKODE THERAPEUTICS ASA (NYKD.OL) Stock Analyst Ratings
Europe - Euronext Oslo - OSL:NYKD - NO0010714785 - Common Stock
2.535 NOK
+0.1 (+4.32%)
ChartMill assigns a Buy % Consensus number of 42% to NYKD.OL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.46. This target is 115.27% above the current price.
NYKD.OL was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about NYKD.OL.
In the previous month the buy percentage consensus was at a similar level.
NYKD.OL was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
NYKODE THERAPEUTICS ASA / NYKD.OL FAQ
What is the average price target for NYKODE THERAPEUTICS ASA (NYKD.OL) stock?
9 analysts have analysed NYKD.OL and the average price target is 5.46 NOK. This implies a price increase of 115.27% is expected in the next year compared to the current price of 2.535.
Can you provide the consensus rating for NYKODE THERAPEUTICS ASA stock?
The consensus rating for NYKODE THERAPEUTICS ASA (NYKD.OL) is 42.2222 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed NYKODE THERAPEUTICS ASA (NYKD.OL)?
The number of analysts covering NYKODE THERAPEUTICS ASA (NYKD.OL) is 9.